Exosomes derived from bone marrow mesenchymal stem cells pretreated with decellularized extracellular matrix enhance the alleviation of osteoarthritis through miR‐3473b/phosphatase and tensin homolog axis
Authors:
- 25 April 2023
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 25 (8) , e3510
Abstract
Background: Osteoarthritis (OA) is a prevalent degenerative articular disease for which there is no effective treatment. Progress has been made in mesenchymal stem cell (MSC)‐based therapy in OA, and the efficacy has been demonstrated to be a result of paracrine exosomes from MSCs. Decellularized extracellular matrix (dECM) provides an optimum microenvironment for the expansion of MSCs. In the present study, we aimed to investigate whether exosomes isolated from bone marrow mesenchymal stem cells (BMSCs) with dECM pretreatment (dECM‐BMSC‐Exos) enhance the amelioration of OA.Methods: Exosomes from BMSCs with or without dECM pretreatment were isolated. We measured and compared the effect of the BMSC‐Exo and dECM‐BMSC‐Exo on interleukin (IL)‐1β‐induced chondrocytes by analyzing proliferation, anabolism and catabolism, migration and apoptosis in vitro. The in vivo experiment was performed by articular injection of exosomes into DMM mice, followed by histological evaluation of cartilage. MicroRNA sequencing of exosomes was performed on BMSC‐Exo and dECM‐BMSC‐Exo to investigate the underlying mechanism. The function of miR‐3473b was validated by rescue studies in vitro and in vivo using antagomir‐3473b.Results: IL‐1β‐treated chondrocytes treated with dECM‐BMSC‐Exos showed enhanced proliferation, anabolism, migration and anti‐apoptosis properties compared to BMSC‐Exos. DMM mice injected with dECM‐BMSC‐Exo showed better cartilage regeneration than those injected with BMSC‐Exo. Interestingly, miR‐3473b was significantly elevated in dECM‐BMSC‐Exos and was found to mediate the protective effect in chondrocytes by targeting phosphatase and tensin homolog (PTEN), which activated the PTEN/AKT signaling pathway.Conclusions: dECM‐BMSC‐Exo can enhance the alleviation of osteoarthritis via promoting migration, improving anabolism and inhibiting apoptosis of chondrocytes by upregulating miR‐3473b, which targets PTEN.Keywords
Funding Information
- National Natural Science Foundation of China (82172413, 81871742, 81971308)
- Shanghai Municipal Hospital Development Center (SHDC2020CR3075B)
This publication has 50 references indexed in Scilit:
- Repair of Large Animal Partial-Thickness Cartilage Defects Through Intraarticular Injection of Matrix-Rejuvenated Synovium-Derived Stem CellsTissue Engineering Part A, 2013
- The functions and regulation of the PTEN tumour suppressorNature Reviews Molecular Cell Biology, 2012
- Osteoarthritis: A disease of the joint as an organArthritis & Rheumatism, 2012
- Expansion on Extracellular Matrix Deposited by Human Bone Marrow Stromal Cells Facilitates Stem Cell Proliferation and Tissue-Specific Lineage PotentialTissue Engineering Part A, 2011
- Cartilage homeostasis in health and rheumatic diseasesArthritis Research & Therapy, 2009
- Comparison of the relative activities of inducing platelet apoptosis stimulated by various platelet-activating agentsPlatelets, 2009
- Cell–matrix adhesionJournal of Cellular Physiology, 2007
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Update on the biology of the chondrocyte and new approaches to treating cartilage diseasesBest Practice & Research Clinical Rheumatology, 2006
- The control of chondrogenesisJournal of Cellular Biochemistry, 2005